197 related articles for article (PubMed ID: 10454092)
41. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
Okada Y; Morodomi T; Enghild JJ; Suzuki K; Yasui A; Nakanishi I; Salvesen G; Nagase H
Eur J Biochem; 1990 Dec; 194(3):721-30. PubMed ID: 2269296
[TBL] [Abstract][Full Text] [Related]
42. Zymographic analysis of latent and activated forms of matrix metalloproteinase-2 and -9 in synovial fluid: correlation to polymorphonuclear leukocyte infiltration and in response to infection.
Makowski GS; Ramsby ML
Clin Chim Acta; 2003 Mar; 329(1-2):77-81. PubMed ID: 12589968
[TBL] [Abstract][Full Text] [Related]
43. Transcriptional and proteolytic regulation of the insulin-like growth factor-I system of equine articular chondrocytes by recombinant equine interleukin-1beta.
Porter RM; Akers RM; Howard RD; Forsten-Williams K
J Cell Physiol; 2006 Nov; 209(2):542-50. PubMed ID: 16897751
[TBL] [Abstract][Full Text] [Related]
44. Equine myeloperoxidase: a novel biomarker in synovial fluid for the diagnosis of infection.
Wauters J; Pille F; Martens A; Franck T; Serteyn D; Gasthuys F; Meyer E
Equine Vet J; 2013 May; 45(3):278-83. PubMed ID: 23145879
[TBL] [Abstract][Full Text] [Related]
45. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.
Armstrong S; Lees P
Am J Vet Res; 1999 Jan; 60(1):98-104. PubMed ID: 9918155
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of creatine kinase and lactate dehydrogenase activities in clinically normal and abnormal equine joints.
Yancik SA; McIlwraith CW; Wagner AE; Trotter GW
Am J Vet Res; 1987 Mar; 48(3):463-6. PubMed ID: 3565903
[TBL] [Abstract][Full Text] [Related]
47. Dose responses to inhalation of endotoxin, hay dust suspension and Aspergillus fumigatus extract in horses as measured by levels and activation of matrix metalloproteinase-9.
Simonen-Jokinen T; Pirie RS; McGorum B; Maisi P
Equine Vet J; 2005 Mar; 37(2):155-60. PubMed ID: 15779629
[TBL] [Abstract][Full Text] [Related]
48. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
Hiramitsu T; Yasuda T; Ito H; Shimizu M; Julovi SM; Kakinuma T; Akiyoshi M; Yoshida M; Nakamura T
Rheumatology (Oxford); 2006 Jul; 45(7):824-32. PubMed ID: 16449361
[TBL] [Abstract][Full Text] [Related]
49. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
50. Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9).
Dreier R; Wallace S; Fuchs S; Bruckner P; Grässel S
J Cell Sci; 2001 Nov; 114(Pt 21):3813-22. PubMed ID: 11719548
[TBL] [Abstract][Full Text] [Related]
51. Equine chondrocyte activation by a variety of stimuli.
May SA; Hooke RE; Lees P
Br Vet J; 1992; 148(5):389-97. PubMed ID: 1422781
[TBL] [Abstract][Full Text] [Related]
52. Expression of matrix metalloproteinase-2 and -9 in human ligamentum flavum cells treated with tumor necrosis factor-α and interleukin-1β.
Kim BJ; Hur JW; Park JS; Kim JH; Kwon TH; Park YK; Moon HJ
J Neurosurg Spine; 2016 Mar; 24(3):428-35. PubMed ID: 26565765
[TBL] [Abstract][Full Text] [Related]
53. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA
Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
[TBL] [Abstract][Full Text] [Related]
54. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.
Bau B; Gebhard PM; Haag J; Knorr T; Bartnik E; Aigner T
Arthritis Rheum; 2002 Oct; 46(10):2648-57. PubMed ID: 12384923
[TBL] [Abstract][Full Text] [Related]
55. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
56. Effects of glucosamine hydrochloride and chondroitin sulphate, alone and in combination, on normal and interleukin-1 conditioned equine articular cartilage explant metabolism.
Dechant JE; Baxter GM; Frisbie DD; Trotter GW; McIlwraith CW
Equine Vet J; 2005 May; 37(3):227-31. PubMed ID: 15892231
[TBL] [Abstract][Full Text] [Related]
57. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
Stanton H; Ung L; Fosang AJ
Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
[TBL] [Abstract][Full Text] [Related]
58. Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage.
Tsuboi H; Matsui Y; Hayashida K; Yamane S; Maeda-Tanimura M; Nampei A; Hashimoto J; Suzuki R; Yoshikawa H; Ochi T
Ann Rheum Dis; 2003 Mar; 62(3):196-203. PubMed ID: 12594102
[TBL] [Abstract][Full Text] [Related]
59. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes.
Sasaki K; Hattori T; Fujisawa T; Takahashi K; Inoue H; Takigawa M
J Biochem; 1998 Mar; 123(3):431-9. PubMed ID: 9538225
[TBL] [Abstract][Full Text] [Related]
60. Fibrous tissue of subchondral cystic lesions in horses produce local mediators and neutral metalloproteinases and cause bone resorption in vitro.
von Rechenberg B; Guenther H; McIlwraith CW; Leutenegger C; Frisbie DD; Akens MK; Auer JA
Vet Surg; 2000; 29(5):420-9. PubMed ID: 10999456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
